No Data
No Data
Insider decrases its stake in Nulab(5033.JP) to 24.59%
On Jul 26, 橋本 正徳 submitted the Change Report to Ministry of Finance. The report shows that 橋本 正徳 decreased their holdings in $Nulab(5033.JP)$, with their joint shareholding ratio down from 24.72% to 2
Nulab: Confirmatory letter.
Nulab: Securities Report - 21st term (April 1, 2023 - March 31, 2024)
Nulab: Interim report
Stocks that moved the day before part 1: sea, Kanamoto, Migarohd, etc.
Stock name <Code> 10-day closing price ⇒ Previous day comparison Showcase <3909> 305 +12 Released the beta version of an AI assistant that supports Cybozu's "kintone" business. Landnet <2991> 1196 +55 Operating profit for the third quarter cumulative increased by 37.4% and the profit growth rate expanded from 6.7% in the previous period. NUROBO <5033> 940 +32 Event of "Backlog" decided to be held nationwide. Kuradashi <5884> 310
Emerging Markets Digest: Trace OP significantly decreased, while J Frontier sharply increased.
<4881> Fanpeppu 176 +17 sharply rose. Buying is expected for the future progress due to the announcement that FPP004X, an allergy vaccine under development, is targeting the first quarter of the 25th year-end for the start of Phase 1 clinical trials after the end of trading on the 7th. The company has signed an option agreement with Shionogi & Co., Ltd. for FPP004X and has the option to acquire exclusive research and development and commercialization rights for all diseases worldwide.
No Data